Compare LZM.WS & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LZM.WS | BCTX |
|---|---|---|
| Founded | N/A | 2014 |
| Country | Isle of Man | Canada |
| Employees | N/A | N/A |
| Industry | Metal Mining | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.4M | 36.6M |
| IPO Year | N/A | 2025 |
| Metric | LZM.WS | BCTX |
|---|---|---|
| Price | $0.40 | $3.67 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 27.3K | ★ 62.6K |
| Earning Date | N/A | 12-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 88.79 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $250.50 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.36 | $2.60 |
| 52 Week High | $0.40 | $13.09 |
| Indicator | LZM.WS | BCTX |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 50.00 |
| Support Level | N/A | $3.50 |
| Resistance Level | N/A | $3.74 |
| Average True Range (ATR) | 0.00 | 0.29 |
| MACD | 0.00 | 0.06 |
| Stochastic Oscillator | 0.00 | 53.98 |
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.